CIK 0001681087 · Non-accelerated filer<br>Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 810710585
- Phone
- (339) 666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-09 | SPRINGER TIMOTHY A Director | Grant or award · Stock Option (Right to Buy) | +10,200 | 10,200 | ||
| 2025-04-11 | SPRINGER TIMOTHY A Director | Purchase | +9,478 | $16.31 | $155K | 4,334,846 |
| 2025-04-11 | SPRINGER TIMOTHY A Director | Purchase | +53,706 | $16.31 | $876K | 1,503,358 |
| 2025-04-10 | SPRINGER TIMOTHY A Director | Purchase | +8,092 | $16.73 | $135K | 4,325,368 |
| 2025-04-10 | SPRINGER TIMOTHY A Director | Purchase | +45,858 | $16.73 | $767K | 1,449,652 |
| 2025-04-09 | SPRINGER TIMOTHY A Director | Purchase | +2,861 | $14.62 | $42K | 4,316,419 |
| 2025-04-09 | SPRINGER TIMOTHY A Director | Purchase | +857 | $15.23 | $13K | 4,317,276 |
| 2025-04-09 | SPRINGER TIMOTHY A Director | Purchase | +16,215 | $14.62 | $237K | 1,398,938 |
| 2025-04-09 | SPRINGER TIMOTHY A Director | Purchase | +4,856 | $15.23 | $74K | 1,403,794 |
| 2025-04-07 | SPRINGER TIMOTHY A Director | Purchase | +87,500 | $17.10 | $1.5M | 4,313,558 |
| 2025-04-07 | SPRINGER TIMOTHY A Director | Purchase | +412,500 | $17.10 | $7.1M | 1,382,723 |
| 2025-04-07 | MCGUIRE TERRANCE Director | Sale | −500,000 | $17.10 | $8.6M | 573,062 |
| 2025-02-05 | SPRINGER TIMOTHY A Director | Purchase | +129,294 | $54.14 | $7.0M | 4,226,058 |
| 2025-02-05 | SPRINGER TIMOTHY A Director | Purchase | +660,000 | $50.00 | $33.0M | 970,223 |
| 2025-02-05 | Lochner Daniel Chief Financial Officer | Purchase | +4,617 | $54.14 | $250K | 4,617 |
| 2025-02-04 | Schwabish Marc Chief Business Officer | Grant or award | +14,023 | 18,723 | ||
| 2025-02-04 | Schwabish Marc Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +25,496 | 25,496 | ||
| 2025-02-04 | McNamara Peter Chief Scientific Officer | Grant or award | +15,141 | 29,329 | ||
| 2025-02-04 | McNamara Peter Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +27,530 | 27,530 | ||
| 2025-02-04 | Lochner Daniel Chief Financial Officer | Grant or award | +18,074 | 18,074 |
Page 5 of 10 · 188 trades